جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

478 مُخرَج نتائج البحث عن «Cancer»

مقالوصول مفتوح2026

Risk factors for irinotecan-induced hepatotoxicity: a retrospective cohort study

Frontiers in Oncology · مجلد 16 · 1777922-1777922

Background Irinotecan is a potent chemotherapeutic agent used as a neoadjuvant in colorectal cancer liver metastasis and significantly enhances five-year survival rates. Recently, irinotecan-associated hepatotoxicity was a significant concern. Given the limited study in this area, we aimed to identify risk factors associated with irinotecan-induced hepatotoxicity. Methods This is a retrospective cohort study at King Saud University Medical City in Riyadh. The study encompassed all adult cancer patients who received irinotecan treatment between Jun 2017 and December 2023. The clinical records of patients were reviewed to assess factors associated with hepatotoxicity. Time-to-event analyses were performed using time-varying exposure. Results The study includes 229 adult cancer patients who received irinotecan-based treatment. Median age was 58 years, and colorectal cancer was the most diagnosed type of cancer (68.6%). Over a median follow-up of 103 days, the incidence of hepatotoxicity was 19.2% (n=44). In the adjusted analysis, higher baseline AST was associated with an increased hazard of hepatotoxicity (HR = 1.01; 95% CI: 1.01–1.02; p = 0.001). Cumulative irinotecan dose showed an inverse association with hepatotoxicity, with lower hazards observed in the medium cumulative dose group (HR = 0.36, 95% CI: 0.14–0.91, p = 0.031) and high cumulative dose group (HR = 0.06, 95% CI: 0.01–0.48, p = 0.008) compared with the low cumulative dose group. Conclusion In summary, an inverse association was observed between cumulative irinotecan dose and hepatotoxicity. A higher baseline AST was also associated with hepatotoxicity, warranting careful assessment of pretreatment liver enzymes and closer monitoring during the early treatment period. Further studies are needed to validate these findings and investigate additional predictors of irinotecan-related hepatotoxicity.

irinotecanhepatotoxicityrisk factorscumulative dose
مقالوصول مفتوح2026

Long-term survival and clinical characteristics of colon and rectal cancer: a comprehensive 47-year retrospective analysis using the SEER database

Annals of Medicine and Surgery · مجلد 88 (7) · 4020-4033

Background: Population screening and therapeutic advances have changed colorectal cancer (CRC) incidence and survival over recent decades, yet important differences exist by anatomic subsite, histology, and population subgroup. This study describes long-term trends in incidence and survival for colon and rectal tumors. Methods: We analyzed 501 094 primary colon and rectal tumor records from the Surveillance, Epidemiology, and End Results (SEER) Incidence database (1975–2022). Age-adjusted rates used the 2000 U.S. standard population. Outcomes were overall survival (OS) and CRC-specific mortality. OS was estimated using Kaplan–Meier methods and compared between groups by log-rank tests. CRC-specific mortality was evaluated using cause-specific Cox regression based on SEER cause-of-death recodes, adjusting for age, sex, race, histology, primary site, and surgery status. Results: Age-adjusted incidence was 48.3 per 100 000. Median OS improved across eras [Era 1 (1975–1994) 3.83 years, Era 2 (1995–2009) 5.58 years, and Era 3 (2010–2022) 6.92 years, all Eras had P value < 0.001). Left- versus right-sided colon cancers and rectal versus colon primaries showed fixed survival differences across eras. Regarding histology, the signet-ring tumors had markedly worse survival, while neuroendocrine/carcinoid tumors showed better long-term survival. In the adjusted Cox model, several colonic subsites showed a higher hazard of CRC-specific death compared to the appendix. Signet-ring cell histology conferred the greatest mortality risk (HR = 2.206, 95% CI 2.113–2.304; P < 0.001). Conclusions: Over a 47-year period, survival in CRC has significantly improved, but outcomes remain influenced by anatomic subsite and histology. These findings confirm that tumor subsite and histology remain important determinants of long-term prognosis in CRC and highlight the need for risk-adapted management strategies, continued population-based surveillance, and ongoing efforts to address disparities in outcomes.

colorectal cancercolon cancerrectal cancerlong-term survival
مقالوصول مغلق2026

Development of a Novel Benzanilide Derivative Targeting VEGFR-2: Computational Modeling and In Vitro Anticancer Validation

Journal of Computational Biophysics and Chemistry · 1-20

The pursuit of selective vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors continues to be a key approach in anticancer drug discovery. In this context, a new benzanilide-based derivative, Z-CMPBC, was designed following essential VEGFR-2 pharmacophoric requirements and investigated through combined computational and biological approaches. Density functional theory (DFT) calculations at the B3LYP/6-31[Formula: see text]G(d, p) level indicated favorable electronic characteristics, including balanced chemical hardness and pronounced electrophilicity, suggesting a strong propensity for interaction within kinase active sites. Molecular docking, supported by 200 ns molecular dynamics simulations, demonstrated stable accommodation of the compound within the VEGFR-2 binding pocket. Binding free energy calculations using the MM-GBSA method revealed a significant interaction profile ([Formula: see text] kcal/mol), mainly governed by van der Waals forces and persistent hydrophobic interactions with critical residues. Biological assessment confirmed potent VEGFR-2 inhibition, with an IC[Formula: see text] value of [Formula: see text]M, closely comparable to sorafenib ([Formula: see text]M). Western blot analysis further verified a reduction in phosphorylated VEGFR-2 (pY1054/Y1059) levels in MCF-7 cells, supporting effective intracellular kinase inhibition. Additionally, Z-CMPBC exhibited pronounced cytotoxicity, particularly against MCF-7 breast cancer cells (IC[Formula: see text]M), along with a high selectivity index ([Formula: see text]) relative to normal Vero cells. Flow cytometry analysis demonstrated induction of G0/G1 phase arrest, accompanied by enhanced apoptotic activity (34.05%) compared to untreated cells. In silico ADMET and toxicity predictions suggested acceptable pharmacokinetic behavior and safety characteristics. Overall, these findings highlight Z-CMPBC as a promising VEGFR-2 inhibitor with potential for further development as an anticancer agent.

VEGFR-2 inhibitorsanticancer drug discoverykinase inhibitorsMCF-7 cells
مقالوصول مفتوح2026

Niclosamide attenuates skin cancer progression through suppression of key oncogenic pathways: integrated in vivo and in-silico mechanistic insights

BMC Cancer · مجلد 26 (1)

Niclosamide, an FDA-approved anti-helminthic drug, has attracted attention for its potential to target multiple cancer-related pathways. This study evaluated the chemopreventive effect of niclosamide in a DMBA/TPA-induced mouse model of skin carcinogenesis and explored its mechanisms using integrated biological and network-based approaches. Mice were treated with niclosamide at 15, 30, and 45 mg/kg and compared with healthy, disease, and standard therapy controls. Tissue and serum analyses were conducted to measure markers of inflammation (TNF-α, IL-6, IL-1β), oxidative stress (MDA, SOD, GSH), apoptosis (caspase-3, Bax/Bcl-2), and angiogenesis (VEGF). Niclosamide reduced tumor volume in a dose-dependent manner, suppressed inflammatory cytokines, restored antioxidant levels, activated apoptotic signaling, and downregulated VEGF expression. A protein-protein interaction network was constructed using eleven experimentally relevant genes to identify key regulatory modules. Network topology and enrichment analysis revealed two functional clusters associated with inflammation, apoptosis, and redox homeostasis. Hub genes such as TNF, IL6, CASP3, and GPX1 highlighted potential interactions among pathways affected by niclosamide. Thus, these findings suggest that niclosamide may exert anticancer effects by modulating interconnected pathways related to inflammation, oxidative stress, apoptosis, and angiogenesis, supporting its potential for further investigation as a repurposed therapeutic candidate for skin cancer.

niclosamideskin cancerchemopreventionDMBA/TPA-induced carcinogenesis
مقالمفتوح (مستودع)2026

Doxorubicin-loaded bacterial ghosts of Streptococcus pneumoniae and Klebsiella pneumoniae : An In-vitro in-silico lung cancer cells study

Journal of King Saud University - Science · مجلد 38 · 3852025-3852025

Lung cancer is the leading cause of cancer-related death in numerous countries worldwide. Given their severe side effects that can impact the patients’ quality of life, the current treatment approaches need more specific targeting to reduce chemotherapeutic toxicities. Cell-based targeted delivery has recently gained momentum as a promising platform for the delivery of anticancer drugs. As a new biotechnology platform, bacterial ghosts (BGs) have novel biomedical applications, including targeted drug delivery systems. In the current work, the BG of Streptococcus pneumoniae and Klebsiella pneumoniae ghosts were used as potential targeted-delivery agents for treating lung cancer cells. Bacterial ghosts of S. pneumoniae and K. pneumoniae were prepared using the most recent protocol (tween/acid). The doxorubicin (DOX) uploading was optimized by applying the required conditions to maximize loading capacity. We evaluated the DOX-loaded BGs’ antiproliferative and apoptotic effects on two lung cancer cell lines (H69A, A549) and one normal human embryonic kidney cell line (HEK293) in comparison to free BGs and DOX alone. We also tested the sustained release patterns for each formula. We predicted the mechanism of augmenting the actions of both systems by a protein-protein docking study. The preparation of well-formulated ghosts of both bacteria was successful and confirmed. The loading capacity was maximized to 31.2 ± 3.1% (n=3) for S. pneumoniae ghosts (SPG) and 28.8± 2.6% (n=3) for K. pneumoniae ghosts (KPG). The sustained release pattern of both SPG and KPG followed the Higuchi kinetic model, while Free DOX exhibited a rapid release pattern consistent with the first-order kinetic model. The antiproliferative activity using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay revealed the superiority of SPG loaded with DOX (SPG-DOX) over all other tested formulae (10.8% viability) on multi-drug-resistant lung cancer cells (H69A). The IC50s of SPG-Dox loaded were one-sixth and one-fifth of the IC50 of the Free DOX in H69A and A549, respectively, indicating more potency. The cell viability was 46.6% upon using Free DOX. In non-small cell lung cancer cells (A549), the SPG-DOX formula also showed superior antiproliferative activity (23.1% viability), as compared to control vehicles. SPG and KPG showed the highest safety toward the normal cell lines (HEK293), with more than 80% of cells surviving. Using H69A cells, KPG-DOX showed superior apoptotic activity (58.2%) over Free DOX, which achieved less than 20% cellular apoptosis. In A549 cells, SPG-DOX showed apoptotic activity of 57.7% compared to Free DOX. (32.5%). The docking study showed a strong binding interaction between a KPG surface protein (4HWM) and the overexpressed non-small cell lung cancer carcinoma receptor, epidermal growth factor receptor kinase domain (EGFR 2ITO), with a binding score (S) for the interaction of -63.94 kcal/mol. The interaction was -61.26 of SPG surface protein (3ZPP) with EGFR. The application of S. pneumoniae and K. pneumoniae BGs loaded with DOX represents a promising targeted drug delivery system for the treatment of lung cancer. The superior potency and safety of both systems warrant further investigation into their preclinical and clinical activities.

bacterial ghostsdoxorubicinStreptococcus pneumoniaeKlebsiella pneumoniae
مقالوصول مغلق2026

Oculoplastic Surgery Knowledge among Ophthalmology Residents. A Saudi Survey-based Study

Annals of African Medicine

BACKGROUND: Oculoplastic surgery is a valuable subspecialty in the field of ophthalmology due to the combined functional and esthetic outcomes of treatment for the eyelid, orbit, lacrimal system, and periorbital structures. While the emphasis on clinical and cosmetic applications of oculoplastic surgery continues to increase, awareness and structured training in the field remain limited within ophthalmology residency programs in Saudi Arabia. OBJECTIVE: The objective of this study was to assess the knowledge, exposure, and perceived value of oculoplastic surgery among ophthalmology residents in Saudi Arabia. MATERIALS AND METHODS: A cross-sectional survey of 102 Saudi Board of Ophthalmology residents, representing 42.7% of the national population, was conducted. A validated 31-item questionnaire was used to collect data, which were subsequently analyzed using SPSS v26. Descriptive statistics and inferential tests (t-test, ANOVA) were used to investigate associations between sociodemographic variables and participants' knowledge scores. RESULTS: The majority of residents (87.3%) demonstrated a good level of knowledge in oculoplastic surgery, with a mean overall score of 13.55 ± 3.37 out of 20. Residents showed a strong understanding of core procedures (i.e., orbital fracture repair, eyelid removal for skin cancer), but there were essential knowledge gaps (i.e., management of thyroid eye disease, surgical prioritization, etc.). Participants' knowledge scores were statistically significant for region of residence (P = 0.004) and training level (P = 0.020). Residents varied widely in training exposure (1-156 weeks). Although the majority of residents (80.4%) were satisfied with their training, they cited barriers to participation (limited accessibility to consultants and cases). The majority of participants (66.7%) recommended additional training time, with some concern about reduced exposure to other subspecialties. CONCLUSION: The overall baseline level of knowledge regarding oculoplastic surgery among ophthalmology residents in Saudi Arabia was at least good, but specific misconceptions were identified. Improved and standardized exposure across training programs could address these gaps and better prepare residents for multidisciplinary care in oculoplastic surgery.

oculoplastic surgeryophthalmology residencyresident knowledgesubspecialty training
مقالوصول مغلق2026

A Critical Review of the Biological Significance and Synthesis Challenges of Phytonutrients

Current Pharmaceutical Design · مجلد 32

These nutraceuticals are bioactive molecules derived from foods that are valuable for human and animal health. They are easy to find, inexpensive, and have fewer side effects than allopathic medicine, and are thus used to treat many diseases. Modern lifestyles, characterized by the high consumption of processed foods, alcohol use, and sedentary behavior, are primary drivers of chronic conditions, including diabetes, obesity, cancer, and neurodegenerative diseases. Even present modern medical therapies have not been able to get rid of side effects and mortality due to therapy. Plant-rich diets, especially fruits and vegetables, are an important part of the development of these compounds, mostly as enhancers of immunity and overall well-being. Nutrition supplements are perceived as having a healthy profile, with safe, easy, and routine incorporation into everyday diets, driven by their growing popularity, rising public awareness, and scientific validation. Nonetheless, the extraction of bioactive compounds from natural sources has faced challenges such as low yields, seasonality, geographic dependence, and the extensive time required for cultivation. In addition, traditional extraction and purification methods for such compounds are slow, resource-intensive, and extremely damaging to the environment through the overuse of solvents and overharvesting of plants, endangering biodiversity. Emerging methods that leverage synthetic and semi-synthetic techniques are increasingly seeking to address challenges in the extraction of bioactive compounds for the large-scale production of high-quality, highly bioactive molecules. This review discusses nutraceutical compounds from various perspectives, including their biological significance and the challenges of extraction and synthesis. Nevertheless, limitations exist, including expensive production costs, complexity of synthesis, and difficulties in replicating natural structures and their activities.

phytochemicalsnutraceuticalsbioactive compoundsnatural product isolation
مقالوصول مغلق2026

Ubiquitin in Human Diseases: Pathophysiology, Dysfunction and Treatment

Current Pharmaceutical Design · مجلد 32

Ubiquitin machinery is an essential regulatory system that maintains protein stability, degradation, and signalling by balancing ubiquitination and deubiquitination. In addition to its classical function in protein tagging for proteasomal degradation, ubiquitin has several essential cellular functions, including cell-cycle regulation, DNA repair, immunomodulation, intracellular signalling, and cellular stress responses. Abnormal regulation of this highly ordered system has been implicated in the pathogenesis of cancer, neurodegenerative diseases, infectious diseases, metabolic dysfunction, and autoimmunity. Recent developments in structural biology, chemical biology, and proteomics have increased our understanding of ubiquitin signalling and identified new therapeutic targets by revealing context-specific interactions within nodes of the ubiquitinproteasome system. Future approaches to restore proteostasis involve selective inactivation of proteasomal subunits, E3 ligases, and deubiquitinating enzymes (DUBs), as well as novel modalities such as proteolysistargeting chimeras (PROTACs) and molecular glues that redirect ubiquitin-dependent degradation of diseaserelevant proteins. Although preclinical and early clinical studies have demonstrated target specificity, longterm safety remains a challenge for clinical translation. This review provides an overview of ubiquitin's pathophysiological functions in key human diseases, therapeutic interventions, and the potential of ubiquitin-based therapeutic strategies for precision medicine and targeted drug therapy.

ubiquitinubiquitin-proteasome systemubiquitinationdeubiquitination
مقالوصول مفتوح2026

Efficacy and long-term impact of HPV vaccination strategies: A Scoping review of clinical trials and follow-up studies

Pharmacy Practice · مجلد 23 (4) · 1-6

Background: Human papillomavirus (HPV) is a leading cause of cervical cancer and other HPV-related cancers globally. Vaccination against HPV has proven to be a pivotal intervention in reducing the burden of these diseases. However, questions remain regarding long-term efficacy, dosing strategies, and real-world outcomes of HPV vaccines. Objective: We aim to synthesise evidence from randomised controlled trials and long-term follow-up studies on the efficacy, immunogenicity, safety, and real-world impact of HPV vaccines. Methodology: A comprehensive search was conducted in PubMed, Cochrane Library, Embase, Scopus, and Web of Science for studies published in English from 2019 to 2024. Eligible studies included randomised controlled trials and long-term follow-up analyses focusing on HPV vaccine efficacy, dosing regimens, and population-specific outcomes. Data were extracted and synthesised narratively, with findings organised into five thematic areas. Results: Seventeen studies met the inclusion criteria. Findings confirm the high efficacy of HPV vaccines in preventing HPV-related cancers and precancers, with durable immunogenicity observed up to 12 years post-vaccination. Evidence supports the potential of single-dose regimens, which could improve accessibility in resource-limited settings. Real-world data demonstrated significant reductions in HPV-related diseases across diverse populations, reinforcing the global impact of HPV vaccination programs. Conclusion: This review highlights the critical role of HPV vaccines in reducing the burden of HPV-related cancers, with robust efficacy, long-term protection, and favourable safety profiles. The findings underscore the need for continued research into optimised vaccination strategies and the expansion of global vaccination efforts.

HPV vaccinationhuman papillomaviruscervical cancer preventionHPV-associated cancers
مراجعةوصول مفتوح2026

A Decade of Oncolytic Virotherapy in Pediatric Cancers: A Systematic Review of Safety, Immune Awakening, and Emerging Efficacy

Cureus · مجلد 18 (1) · e101744-e101744

Oncolytic virotherapy employs genetically modified viruses to selectively lyse tumor cells while activating antitumor immune responses. In pediatric oncology, where outcomes for high-grade gliomas and refractory solid tumors remain poor, oncolytic viruses represent a promising therapeutic strategy. A systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, including searches of PubMed, Embase, Scopus, Web of Science, and ClinicalTrials.gov for studies published between 2015 and 2025 that evaluated oncolytic virotherapy in patients aged 18 years or younger. Data on safety, efficacy, and immune-related outcomes were extracted, study quality was assessed using the Risk Of Bias In Non-randomized Studies - of Interventions (ROBINS-I) tool, and the certainty of evidence was evaluated using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) framework. Ten early-phase clinical trials involving 115 pediatric patients met the inclusion criteria. Investigated viral platforms included herpes simplex virus type 1 (G207, HSV1716), adenovirus (DNX-2401, ICOVIR-5, Ad-TD-nsIL12), T-VEC (HSV-1), poliovirus (PVSRIPO), Seneca Valley virus, and reovirus. Across studies, no treatment-related deaths or persistent grade 3 or higher toxicities were reported, and adverse events were generally mild and transient. Radiologic or clinical disease control rates ranged from 20% to 90%, with median overall survival between 11 and 18 months in selected central nervous system tumor cohorts. Translational analyses demonstrated increased CD8⁺ T-cell infiltration, upregulation of interferon-γ and interleukin-6 signaling pathways, and evidence of transient viral replication, supporting immune-mediated antitumor mechanisms. Overall risk of bias was moderate, while the certainty of evidence was rated as low for safety outcomes and very low for efficacy. These findings indicate that oncolytic virotherapy is safe, feasible, and biologically active in children with malignant brain and solid tumors, and that preliminary survival signals and consistent immune activation support further investigation through larger, multicenter randomized trials and combination strategies with radiotherapy or immune checkpoint inhibitors.

oncolytic virotherapychildhood cancerhigh-grade gliomarefractory solid tumors
مقالوصول مغلق2026

Factors Influencing Breast Cancer Survival Outcomes in the Central Region of Saudi Arabia.

PubMed · مجلد 1 (50) · 56-64

BACKGROUND: Globally, breast cancer (BC) stands as the most common malignancy, predominantly affecting women, with observed trends of increasing incidence and mortality. Data concerning the survival of BC patients in Saudi Arabia (SA) is notably scarce. This study aims to pinpoint the specific factors that impact the survival rate (SR) among breast cancer patients in Saudi Arabia's central region. METHODS: This retrospective study analyzed data from 1405 breast cancer patients documented in the King Abdulaziz Medical City Cancer Registry from 2009 to 2018. The collected patient information included sociodemographic details and comprehensive tumor characteristics such as its location, histopathology, molecular subtypes, disease stage, and ultimate survival outcomes. To assess the relationship between these factors and patient survival, survival analyses were performed, incorporating Kaplan-Meier curves and Cox regression models, which were adjusted for potential confounding variables. RESULTS: Patients of older age (over 60 years) demonstrated a higher mortality risk from breast cancer. Invasive ductal carcinoma was the most frequently observed histopathologic subtype; however, invasive lobular carcinoma was linked to an elevated death risk. Adjusted Hazard Ratios from Cox regression indicated that BC patients with metastasis were six times (AHR=6.3; 95%CI=4.6-8.7, p<0.001) more likely to face a higher death risk compared to those with localized or regional tumors. Furthermore, patients diagnosed with triple-negative tumors were associated with twice the risk of death compared to other subtypes (AHR=2.1; 95%CI=1.4-2.9, p<0.001). CONCLUSION: Both patient age and the presence of distant cancer spread are critical predictors of survival for breast cancer patients residing in central Saudi Arabia. Emphasizing early diagnosis, timely treatment, and consistent follow-up is essential for enhancing patient outcomes.

breast cancersurvival outcomesprognostic factorsage at diagnosis